Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. (Q53976561)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

0 references

Cytomegalovirus

0 references

Cecilia Söderberg-Nauclér

7

object named as

Söderberg-Nauclér C

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

author name string

Odeberg J

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Cerboni C

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Browne H

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Kärre K

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Möller E

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Carbone E

6

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

55

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

149-161

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

Severe herpesvirus infections in an adolescent without natural killer cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Persistent cytomegalovirus infection: Association with profound immunodeficiency and treatment with interferon

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

NK cell receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

NK-cell receptors and recognition of MHC class I molecules

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Early signaling via inhibitory and activating NK receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01025.X

21 January 2018

Identifiers

10.1046/J.1365-3083.2002.01025.X

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11896931

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53976561&oldid=1151011171"